Skip to content

Avastin

Page last modified on: May 8, 2008

Avastin (chemical name: bevacizumab) is a targeted therapy that was approved by the U.S. Food and Drug Administration (FDA) in combination with Taxol (chemical name: paclitaxel) in February 2008 to treat people with metastatic HER2-negative breast cancer who haven't yet received chemotherapy for metastatic breast cancer.

In this section you can read about:

Avastin is also approved by the FDA to treat advanced cancers of the lung, colon, and rectum.

 

wellness_dvd_promo

Email Updates

Stay informed about current research, online events, and more.

Please leave this field empty
Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2009 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.